MENU

HELP Cybin Inc Forecast, Technical & Fundamental Analysis

Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways... Show more

HELP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
HELP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TQCAX21.64N/A
N/A
Touchstone Dividend Equity A
UDPIX102.75N/A
N/A
ProFunds Ultra Dow 30 Inv
ARBNX14.20N/A
N/A
Arbitrage I
FFTMX23.57N/A
N/A
Fidelity Advisor Asset Manager 50% M
CISMX12.61N/A
N/A
Clarkston Partners Institutional
Cybin (HELP) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com